| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.05 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.31 | 0.06 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |